-+ 0.00%
-+ 0.00%
-+ 0.00%

GlucoTrack names Erik Emerson CEO, Paul Goode CTO in Lōkahi deal

PUBT·07/14/2026 21:40:30
Listen to the news
GlucoTrack names Erik Emerson CEO, Paul Goode CTO in Lōkahi deal
  • GlucoTrack named Erik Emerson chief executive officer following the completion of its business combination with Lōkahi Therapeutics.
  • Paul Goode was appointed chief technical officer of the combined company, retaining responsibility as chief executive officer of the CBGM subsidiary.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607141740PRIMZONEFULLFEED9762297) on July 14, 2026, and is solely responsible for the information contained therein.